The pharmacokinetics of azilocilin, a new wide-spectrum antibiotic of the Nsubstituted group of ureidomethyl penicillins, was investigated in 10 subjects with normal and in 32 subjects with impaired renal functions. After intravenous injection of 2 g of azlocillin, serum concentrations of drug were measured microbiologically. The half-lives of azlocillin wete 47 ± 8.8 min in patients with normal renal function, and 293.3 min in patients with severely impaired renal function. 
MATERIALS AND METHODS
Azlocillin was tested in 10 healthy volunteers with normal renal function and in 32 patients of a nephrological outpatient clinic, most of whom had impaired renal function. Ages ranged from 17 to 62 years, with the mean age being 42.4 ± 14.3 years. The mean height was 167.7 ± 10.3 cm, and the mean weight was 66.1 ± 13.1 kg.
Each subject received an intravenous bolus injection of 2 g of azlocillin dissolved in 20 ml of doubledistilled water, the mean dose was 32 ± 6 mg/kg of body weight. The first blood sample was drawn after 0.5 h, and, an additional nine samples were taken at 30-min intervals over the next 6 h (in severely impaired renal function the collecting period was prolonged up to 10 h). The glomerular filtration rate was determined by measurement of the 51Cr-ethylenediaminetetraacetate clearance (2) and converted into inulin clearance (Clh.) rates.
Urine was collected at four intervals, 0 to 2, 2 to 4,RESULTS Serum concentrations of azlocillin, as measured at intervals in 10 healthy volunteers, are shown in a semilogarithmic plot in Fig. la 
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The individual data of the examined subjects in both groups are listed in Table 1 . There is a remarkable difference in ages in the two groups. Whereas the half-lives in healthy volunteers have been in a narrow range, there are naturally major differences in patients with severely impaired renal functions. The average half-life for ten subjects with normal renal function and an average body weight of 71.5 kg was 47.6 + 8.8 rin, as compared with an average half-life of 293.3 min in the eight patients with severely impaired renal function.
The azlocillin serum half-lives for normal subjects and for subjects with all ranges of impaired renal function are plotted against Clhn in Fig. 2 h was 51.9%, or 80.1% of the total. In the next 2 h, only 9.4% azlocillin was found in the urine samples, and in the subsequent two 2-h urine samples, only 2.2 and 1.3%, respectively, were found (Fig. 3) . The average urinary excretion of azlocillin was 64.8 ± 8.8% in 24 h. There was no relationship between amount excreted and urine volume.
The average protein binding for five persons with nonnal renal function was 27.9 ± 6.1% (average total protein, 7.48 g/100 ml), and that for four patients on regular hemodialysis was 25 1.6% (average total protein, 6 .88 g/100 ml). (5) the mean serum half-life after intravenous administration of 2 g of carbenicillin is 60 ± 0.15 min, which is slightly longer than that of azlocillin. A correlation of half-life to renal function, which can be expressed mathematically by an exponential function, is also found for other antibiotics in the penicillin group, such as carbenicillin, ticarcillin, and ampicillin (4) .
DISCUSSION
We found a urinary excretion rate of 64.8% in 24 h after a dose of 2 g of azlocillin; in earlier studies rates of 44 and 57% (studies done at Bayer AG) and 59% (10) were found. The urinary excretion rates found for ampicillin are 80% (9) and 63.8 to 69.1% (7), and for carbenicillin they are 84% (9) and 76% (6) . Thus, the total percentage of the dose of azlocilhin excreted in urine is slightly lower than that of carbenicillin but similar to that of ampicillin.
The slight difference in protein binding between normal persons and uremic subjects is not significant.
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